Companies · Hospitals and Physicians

TN HoldCo, Inc.

KNOXVILLE · Hospitals and Physicians

Diligence memoA one-page analyst read on TN HoldCo, Inc. — recommendation, valuation, rhythm, risks.
$406.9M
Total raised · real
2
Rounds
1.2×
Latest step-up
Top 2%
Sector rank · raised
Series D+
Latest stage · inferred · Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

TN HoldCo, Inc. has raised $407M over 2 rounds; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health services sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Dormant
  • Last raise 6.3 yr ago; this sector typically re-raises about every 12 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Hospitals and Physicians

TN HoldCo, Inc. is one of 599 Hospitals and Physicians companies tracked from KNOXVILLE. By capital raised it ranks among the largest (ahead of 99% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
180
Investors (latest)
2020-02-25
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$2.5B$5.0B$7.5B$10.0BSeries D+ · 2017-07-07 Raised $214M (real) Modeled valuation $4.6B (est)Series D+2017Series D+ · 2017-07-07 Raised $234M (real) Modeled valuation $5.0B (est)Series D+2017Series D+ · 2017-07-07 Raised $244M (real) Modeled valuation $5.2B (est)Series D+2017Series D+ · 2020-02-25 Raised $157M (real) Modeled valuation $3.4B (est)Series D+2020Series D+ · 2020-02-25 Raised $163M (real) Modeled valuation $3.5B (est)Series D+2020Series D+ · 2020-02-25 Raised $151M (real) Modeled valuation $3.2B (est)Series D+2020Series C · 2020-02-25 Raised $84M (real) Modeled valuation $1.8B (est)Series C2020Series D+ · 2020-02-25 Raised $159M (real) Modeled valuation $3.4B (est)Series D+2020Series D+ · 2020-02-25 Raised $140M (real) Modeled valuation $3.0B (est)Series D+2020Series D+ · 2020-02-25 Raised $165M (real) Modeled valuation $3.5B (est)Series D+2020+$234M+$244M+$157M+$163M+$151M+$84M+$159M+$140M+$165MCumulative $1.7B

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series D+$214.1M · 2017
Series D+ extension$234.1M · 2017
Series D+ extension$244.0M · 2017
Series D+ extension$157.1M · 2020
Series D+ extension$162.8M · 2020
Series D+ extension$150.8M · 2020
Bridge · Series D+-stage$84.3M · 2020smaller follow-on
Series D+ extension$159.0M · 2020
Series D+ extension$139.9M · 2020
Series D+ extension$165.5M · 2020

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$3.5B
Base estimate est.
$904.1M
Conservative case
$7.6B
Upside case
$1.4B
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series D+a $100M–$400M round). Valuation is modeled from stage benchmarks scaled by the health services sector profile. Directional, not a quoted figure.

Series D+ · modeled $4.6B · 2017-07-072017Series D+ · modeled $5.0B · 2017-07-07Series D+ · modeled $5.2B · 2017-07-07Series D+ · modeled $3.4B · 2020-02-25Series D+ · modeled $3.5B · 2020-02-25Series D+ · modeled $3.2B · 2020-02-25Series C · modeled $1.8B · 2020-02-25Series D+ · modeled $3.4B · 2020-02-25Series D+ · modeled $3.0B · 2020-02-25Series D+ · modeled $3.5B · 2020-02-252020
Model inputs · modeled:benchmark-stage-stepup-v1
12%
Dilution assumption
Implied ownership sold in the financing.
83%
Survival probability
67% low · 92% high
1.21×/yr
Annual markup
1.35×/yr upside case
6.0 yr
Elapsed time used
6.3 yr actual, capped for stale marks
health services
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
4 mo
Avg between rounds
$154.3M/yr
Capital velocity
9.0 yr
On record since
2017
First round
10
Rounds on file
How it compares to the market

Benchmarked against 599 companies in Hospitals and Physicians. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 224× above median
This company$406.9M
Sector median$1.8M
Latest round — vs other Series D+ rounds in sector (real $, this stage) 1.1× above median
This company$165.5M
Sector median$145.4M
Modeled value — vs sector median (estimate, all stages) 152× above median
This company$3.5B
Sector median$22.9M

Raised more than 99% of sector peers (real $). Modeled value above 99% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series D+) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful.

Not enough valued peers in this cohort to chart positioning.

CompanyStageRaised · realValue · estvs peer med.
Quincy Health, LLCSeries D+$200.0M$4.3B1.10×
TN HoldCo, Inc. this companySeries D+$406.9M$3.5B0.90×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series D+$214.1M2017-07-07$1.8B$4.6B90%
Series D+$234.1M2017-07-07$2.0B$5.0B90%
Series D+$244.0M2017-07-07$2.0B$5.2B90%
Series D+$157.1M2020-02-25$1.3B$3.4B90%
Series D+$162.8M2020-02-25$1.4B$3.5B90%
Series D+$150.8M2020-02-25$1.3B$3.2B90%
Series C$84.3M2020-02-25$562.2M$1.8B90%
Series D+$159.0M2020-02-25$1.3B$3.4B90%
Series D+$139.9M2020-02-25$1.2B$3.0B90%
Series D+$165.5M2020-02-25$1.4B$3.5B90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series D+$214.1M2017-07-07
    • First recorded raise — entered as Series D+.
    • 106 investors on this round.
  2. Series D+$234.1M2017-07-07
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 145 investors on this round.
  3. Series D+$244.0M2017-07-07
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 141 investors on this round.
  4. Series D+$157.1M2020-02-25
    • Raised again after 32 mo — slower than the ~12 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
    • 168 investors on this round.
  5. Series D+$162.8M2020-02-25
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 181 investors on this round.
  6. Series D+$150.8M2020-02-25
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 141 investors on this round.
  7. Series C$84.3M2020-02-25
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.8× smaller than the prior — bridge or down round.
    • 121 investors on this round.
  8. Series D+$159.0M2020-02-25
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.9× larger than the prior — scaling up.
    • 160 investors on this round.
  9. Series D+$139.9M2020-02-25
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 141 investors on this round.
  10. Series D+$165.5M2020-02-25
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 180 investors on this round.
Intelligence
2020 ~Q2
Modeled next raise · ~4mo cadence
$195.7M
Modeled next size est.range $165.5M$313.2M
1.2×
Last step-up
$154.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David Jones18 other2017-07
Julia Monfrini Peev8 other2017-07
Bruce McEvoy2 other2017-07
Michael Weichart2 other2017-07
Anushka M. Sunder1 other2017-07
H. Lynn Massingale1 other2017-07
Leif M. Murphy1 other2017-07
Leif Murphy1 other2017-07
Neil Simpkins1 other2017-07
A.J. M. Brohinsky2017-07
Bob Galvin2017-07
Bruce M. McEvoy2017-07
Francois Dufresne2017-07
Francois M. Dufresne2017-07
Francois W. Dufresne2020-02
Justin Sunshine2017-07
Keith M. Sherin2017-07
Keith W. Sherin2020-02
Marylene W. Roy2020-02
Michael Wiechart2017-07
Neil M. Simpkins2017-07
Neil W. Simpkins2020-02
Phil McSween2017-07
Phil M. Roe2017-07
Registry & provenance

TN HoldCo, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1712373
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
1Life Healthcare IncHospitals and PhysiciansSeries D+$325.5M$4.7Bsame sector · same stage
Georgia Proton Treatment Holdings, LLCHospitals and PhysiciansSeries D+$313.3M$2.7Bsame sector · same stage
United Digestive Holdings, LLCOther Health CareSeries D+$323.3M$4.2Bnetwork1 shared operator · same stage
Ivy Holdings Inc.Hospitals and PhysiciansSeries D+$208.7M$4.5Bsame sector · same stage
Quincy Health, LLCHospitals and PhysiciansSeries D+$200.0M$4.3Bsame sector · same stage
Kentucky Homecare Parent, Inc.Hospitals and PhysiciansSeries D+$145.4M$3.1Bsame sector · same stage
Sdg Holding Company, LlcHospitals and PhysiciansSeries D+$140.9M$30.5Msame sector · same stage
Dallas Proton Treatment Center, LLCHospitals and PhysiciansSeries D+$140.0M$971.8Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Voigtlander Holdco, LLCHospitals and PhysiciansSeed$17.5M88%
ACM Holdco, LPHospitals and PhysiciansSeries C$2.1B85%
Contractual Holdco Management, LLCOther Health CareSeries B$207.0M83%
Udc Holdco, LlcOther Health CareSeries B$17.3M83%
RMX Holdco, Inc.Other Health CareSeries C$720.5M83%
VitalCare Holdco, Inc.Other Health CareSeed$4.9M83%
OneOncology Management Holdco, LLCOther Health CareSeries C$807.9M82%
EDS Holdco LLCOther Health CareSeries A$221.5M82%
Frequently asked
How much funding has TN HoldCo, Inc. raised?
TN HoldCo, Inc. has raised approximately $406.9M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is TN HoldCo, Inc.'s estimated valuation?
Provath's modeled valuation for TN HoldCo, Inc. is approximately $3.5B (modeled range $904.1M–$7.6B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is TN HoldCo, Inc. at?
TN HoldCo, Inc.'s latest modeled financing stage is Series D+. Its most recent recorded round closed around Tue Feb 25.
What does TN HoldCo, Inc. do and where is it based?
TN HoldCo, Inc. operates in the Hospitals and Physicians sector, based in KNOXVILLE.
Explore related

See where TN HoldCo, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at TN HoldCo, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.